FDA Inspection
Samuel F Hunter, MDSamuel F Hunter, MD – FDA Inspection, Feb 13, 2015
Record Details
This FDA Inspection record concerns Samuel F Hunter, MD, with an inspection on February 13, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Samuel F Hunter, MD
- Inspection Date
- February 13, 2015
- Product Type
- Drugs
View Company Profile
ID · 1300d538-9a0a-4dc6-abab-bdfecd9b2579
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 918069
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 312.64(b)Safety reports
- 21 CFR 50.25(c)ClincialTrials.gov statement
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Samuel F Hunter, MD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 18, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Samuel F Hunter, MD
- FDA Inspection 1192725 - 2022-11-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.